Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A Safety and Efficacy Extension Study of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
Biogen Idec and AbbVie announce positive top-line results from Phase 3 study investigating daclizumab high-yield process in multiple sclerosis
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
Getting a Handle on Lymphopenia With Tecfidera
Headwaters of the zebrafish -- emergence of a new model vertebrate.
Regulation of B cell function by the immunosuppressive agent leflunomide.
A map of the human neocortex showing the estimated overall myelin content of the individual architectonic areas based on the studies of Adolf Hopf.
Copaxone
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Our Products (page shows "Copaxone" as a trade name for glatiramer acetate)
Long-term effectiveness of glatiramer acetate in clinical practice conditions.
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
[Reduction of spastic increased muscle tone in multiple sclerosis by the nonopioid analgesic flupirtine].
Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.
Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease.
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
Ethnicity and prevalence of multiple sclerosis in east London.

Pages